Published in Regul Pept on September 03, 1992
Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci U S A (2000) 1.38
Neuropeptide Y in the central nucleus of the amygdala suppresses dependence-induced increases in alcohol drinking. Pharmacol Biochem Behav (2008) 1.23
Viral vector-induced amygdala NPY overexpression reverses increased alcohol intake caused by repeated deprivations in Wistar rats. Brain (2007) 1.14
Neuropeptide Y receptor gene expression in the primate amygdala predicts anxious temperament and brain metabolism. Biol Psychiatry (2013) 1.14
The role of neuropeptide Y in the expression and extinction of fear-potentiated startle. J Neurosci (2008) 1.14
Neuropeptide modulation of central amygdala neuroplasticity is a key mediator of alcohol dependence. Neurosci Biobehav Rev (2011) 1.04
Effect of pharmacological manipulations of neuropeptide Y and corticotropin-releasing factor neurotransmission on incubation of conditioned fear. Neuroscience (2009) 0.98
Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y. Physiol Behav (2012) 0.98
Corticotropin-releasing factor (CRF) and neuropeptide Y (NPY): effects on inhibitory transmission in central amygdala, and anxiety- & alcohol-related behaviors. Alcohol (2012) 0.90
Cell-specific expression of neuropeptide Y Y1 receptor immunoreactivity in the rat basolateral amygdala. J Comp Neurol (2009) 0.88
Neuropeptide Y administration into the amygdala suppresses ethanol drinking in alcohol-preferring (P) rats following multiple deprivations. Pharmacol Biochem Behav (2008) 0.87
Targeting the Neuropeptide Y System in Stress-related Psychiatric Disorders. Neurobiol Stress (2015) 0.87
Neuropeptide Y (NPY) in the extended amygdala is recruited during the transition to alcohol dependence. Neuropeptides (2012) 0.82
Differential Regulation of Neuropeptide Y in the Amygdala and Prefrontal Cortex during Recovery from Chronic Variable Stress. Front Behav Neurosci (2011) 0.82
Effects of neuropeptide Y and ethanol on arousal and anxiety-like behavior in alcohol-preferring rats. Alcohol (2010) 0.80
Neuropeptide Y (NPY) in the central nucleus of the amygdala (CeA) does not affect ethanol-reinforced responding in binge-drinking, nondependent rats. Pharmacol Biochem Behav (2011) 0.78
Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res (1993) 2.27
Detection of Salmonella infection by ELISA. Vet Rec (1989) 2.08
CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology (Berl) (1991) 2.04
Choriocapillaris degeneration and related pathologic changes in human diabetic eyes. Arch Ophthalmol (1998) 1.64
Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci (1994) 1.61
Development and application of polymerase chain reaction (PCR) tests for the detection of subgroup J avian leukosis virus. Virus Res (1998) 1.43
Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology (1993) 1.43
Corticosteroids for bacterial corneal ulcers. Br J Ophthalmol (2008) 1.40
The role of corticotropin-releasing factor in behavioural responses to stress. Ciba Found Symp (1993) 1.38
Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res (1992) 1.35
A sensitive open field measure of anxiolytic drug activity. Pharmacol Biochem Behav (1981) 1.23
Periconceptual folate supplementation. Br J Gen Pract (1996) 1.22
The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat. Behav Brain Res (1999) 1.14
Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41). Neuropsychopharmacology (1989) 1.13
The role of CRF in behavioral aspects of stress. Ann N Y Acad Sci (1995) 1.13
The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors. Eur J Pharmacol (1997) 1.12
Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat. Brain Res (1986) 1.05
Bovine spongiform encephalopathy. Media coverage had shortlived effect on beef consumption by pregnant women. BMJ (1996) 1.05
Real-time measurement of glutamate release from the ischemic penumbra of the rat cerebral cortex using a focal middle cerebral artery occlusion model. Neurosci Lett (2001) 1.01
Molecular characterization of multiresistant strains of Salmonella typhi from South Asia isolated in Ontario, Canada. Can J Microbiol (1998) 1.00
Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity. Neuropsychopharmacology (1994) 0.98
Quinolone resistance in clinical strains of Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother (1995) 0.97
Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat. Psychopharmacology (Berl) (2001) 0.94
Detection of visual-field deterioration by Glaucoma Progression Analysis and Threshold Noiseless Trend programs. Br J Ophthalmol (2008) 0.94
Picrotoxinin receptor ligand blocks anti-punishment effects of alcohol. Alcohol (1989) 0.92
Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone. Life Sci (1986) 0.89
Increasing incidence of resistance among shigellae to trimethoprim. Lancet (1991) 0.88
Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cytotoxicity. J Pharmacol Exp Ther (1990) 0.87
CRF activates autonomic nervous system and reduces natural killer cytotoxicity. Am J Physiol (1988) 0.86
Associations of BF2 alleles with antibody titres and production traits in commercial pure line broiler chickens. Anim Genet (2007) 0.84
MX1 exon 13 polymorphisms in broiler breeder chickens and associations with commercial traits. Anim Genet (2007) 0.84
Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test. Psychopharmacology (Berl) (1985) 0.84
The impact of a managed care network on attendance, follow-up and treatment at a hepatitis C specialist centre. J Viral Hepat (2010) 0.83
Is ethanol antagonist Ro15-4513 selective for ethanol? Science (1988) 0.83
Both conditioned taste preference and aversion induced by corticotropin-releasing factor. Pharmacol Biochem Behav (1991) 0.83
Short latency somatosensory evoked potentials in patients with neurological lesions. Arch Neurol (1979) 0.83
Rapid identification of single nucleotide polymorphisms and estimation of allele frequencies using sequence traces from DNA pools. Poult Sci (2006) 0.81
Intravenous drug use: not a barrier to achieving a sustained virological response in HCV infection. J Viral Hepat (2011) 0.81
Dorsal noradrenergic bundle lesions fail to alter opiate withdrawal or suppression of opiate withdrawal by clonidine. Life Sci (1984) 0.80
Construct validity of the FOCUS© (Focus on the Outcomes of Communication Under Six): a communicative participation outcome measure for preschool children. Child Care Health Dev (2013) 0.80
Emergence in Ontario, Canada, of multiresistant Salmonella typhi from South Asia. Lancet (1992) 0.79
Anxiolytic effects of steroid hormones during the estrous cycle. Interactions with ethanol. Recent Dev Alcohol (1995) 0.79
Cardiovascular actions of neuropeptide Y and social stress. Peptides (1998) 0.78
Endocrine, immune, and neurochemical changes in rats during withdrawal from chronic amphetamine intoxication. Neuropsychopharmacology (1991) 0.78
Identification of high-potency neuropeptide Y analogues through systematic lactamization. J Med Chem (1997) 0.78
Genetic variation at the tumour virus B locus in commercial and laboratory chicken populations assessed by a medium-throughput or a high-throughput assay. Avian Pathol (2007) 0.78
The influence of experimental distemper infection on the distribution of lead in dogs previously subacutely intoxicated with lead carbonate. Br J Exp Pathol (1975) 0.78
Pregnane steroid alphaxalone attenuates anxiogenic behavioral effects of corticotropin releasing factor and stress. Pharmacol Biochem Behav (1992) 0.77
The effects of Ro 15-4513 on the behavioral actions of ethanol in an operant reaction time task and a conflict test. Pharmacol Biochem Behav (1988) 0.77
Stress, performance, and arousal: focus on CRF. NIDA Res Monogr (1990) 0.77
Ultrastructural plasticity in stimulated nerve terminals: pseudopodial invasions of abutted terminals in Torpedine ray electric organ. Neuroscience (1979) 0.77
Central corticotropin-releasing factor suppresses natural killer cytotoxicity. Brain Behav Immun (1987) 0.77
Features of developmental dyspraxia in the general speech-impaired population? Clin Linguist Phon (1998) 0.77
Alphaxalone, a steroid anesthetic, inhibits the startle-enhancing effects of corticotropin releasing factor, but not strychnine. Psychopharmacology (Berl) (1994) 0.76
Effects of naloxone on anti-conflict and hyperphagic actions of diazepam. Life Sci (1981) 0.76
Supersensitive endocrine response to physostigmine in dopamine-depleted rats: a model of depression? Biol Psychiatry (1986) 0.76
Neuropharmacology. Premenstrual steroids? Nature (1998) 0.76
Brain norepinephrine depleting lesions selectively enhance behavioral responsiveness to novelty. Physiol Behav (1984) 0.75
Remifentanil and seizures. Anaesthesia (2000) 0.75
Experimental canine distemper infection as a means of demonstrating latent effects of subacute lead intoxication. Br J Exp Pathol (1976) 0.75
Evaluation of a commercial avian leukosis ELISA kit for detecting hens which shed leukosis virus to their progeny. Avian Pathol (1983) 0.75
Evaluation of serum guanase as a liver function test. Can J Med Technol (1967) 0.75
Indirect antigen-trap ELISAs using polyclonal antisera for detection of group B and D Salmonellas in chickens. Avian Pathol (1991) 0.75
Psycholinguistic models of speech development and their application to clinical practice. J Speech Lang Hear Res (2001) 0.75
Diagnostic methods for chlamydial infections in a high-risk population. Va Med (1989) 0.75
Large herbivore population dynamics. Trends Ecol Evol (1997) 0.75
Nursing at Henwood Rehabilitation Center. AARN News Lett (1985) 0.75
Effects of corticotropin-releasing factor on circadian locomotor rhythm in the golden hamster. Pharmacol Biochem Behav (1998) 0.75
MMPI-2 patterns in African-American females. J Clin Psychol (1996) 0.75